SFSimon Martin Frey

Simon Martin Frey

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Simon Martin Frey has a total of 191 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Temporal trends in pretest probability and normal scan rates in myocardial perfusion imaging: a 24-year experience from a Swiss tertiary referral center (between 2000 and 2024)

    by Simon M Frey, Igor G Schneider, Ann-Sophie Otto, Florian M Geiser, Damian Wild, Philip Haaf, Felix Mahfoud, Michael J Zellweger

    Introduction: Myocardial perfusion imaging (MPI) is widely used to assess coronary artery disease (CAD). U.S. studies have reported increasing normal MPI findings over time. However, European data are limited. This study examined temporal trends in pre-test probability (PTP) and MPI findings at a large Swiss centre. Methods and results: In this retrospective study, 45 686 MPI scans were analysed. Clinical data included demographics, symptoms, risk factors, MPI results, and coronary artery calcium score (CACS). Endpoints were defined as abnormal MPI (Summed Stress Score ≥4), small ischaemia (Summed Difference Score ≥2), and relevant ischaemia (≥10% ischaemia). PTP was calculated using the 2013/2019 ESC chronic coronary syndrome (CCS) guidelines, and risk factor–weighted clinical likelihood (RF-CL) from the 2024 guidelines. Normal MPI results increased significantly over time (53% (2000) → 66% (2024), P < 0.001), irrespective of unchanged PTP/RF-CL, modality, type of stress, symptoms and risk factors. Small ischaemia decreased (37.6% → 34.2%), while relevant ischaemia increased (11.0% → 13.2%, P < 0.001 each) slightly. SSS and SRS decreased significantly, whereas SDS remained unchanged. CACS and the prevalence of zero CACS remained unchanged over time. ESC PTP models overestimated the prevalence of abnormal MPI and small ischaemia. Only RF-CL predicted relevant ischaemia correctly in very low-risk patients. Conclusion: The rate of normal MPI results increased over time, but the trend was less pronounced than previously published. Possible explanations include referral of healthier patients (unchanged CACS despite increasing age), less typical angina, a lower prevalence of established CAD, and more female patients.


  • Open Access

    Evaluation of risk factor-weighted and coronary artery calcium score-weighted clinical likelihoods as gatekeepers before advanced ischemia testing

    by Simon M. Frey, Igor G. Schneider, Ann-Sophie Otto, Florian M. Geiser, Fiona Nafaa, Gabrielle Huré, Jinju Elavathingal, Karolina Sobolewska, Klara Rumora, Damian Wild, et al.

  • Diagnostic Accuracy of Fourth Universal Definition ECG Criteria for Identifying Prior Myocardial Infarction

    by Martin Segeroth, Patrick Badertscher, Ivo Strebel, Jan Gerrit van der Stouwe, Jude Formambuh, Federico Caobelli, Antonio Madaffari, Gregor Sommer, Pedro Lopez-Ayala, Simon M. Frey, et al.

    Compared with cardiac MRI as the reference standard, electrocardiographic criteria demonstrated high specificity but limited sensitivity for detecting prior myocardial infarction, particularly in lateral and subendocardial regions.


  • Open Access

    Prognostic value of myocardial perfusion imaging in asymptomatic high-risk diabetic patients: 10-year follow-up of the prospective multicentre BARDOT trial

    by Kathrin Thommen, Simon M Frey, Daniel Kammerer, Damian Wild, Philip Haaf, Felix Mahfoud, Michael J Zellweger, the BARDOT investigators, Jan Müller-Brand, Miriam Brinkert, et al.

    Aims: Patients with type 2 diabetes mellitus (T2DM) are at high risk for coronary artery disease (CAD) related events and are often asymptomatic. The role of cardiac imaging in screening asymptomatic T2DM patients remains controversial, as existing studies are limited by short follow-up periods. Therefore, study aim was to provide long-term (10 years) outcome data of T2DM patients screened with cardiac imaging. Methods and results: A total of 400 asymptomatic high-risk T2DM patients without history of CAD underwent screening with Single Photon Emission Computed Tomography (SPECT). Abnormal SPECT was defined as Summed Stress Score ≥ 4 or Summed Difference Score ≥ 2. Patients were followed for all-cause mortality and major adverse cardiovascular events (MACE, cardiovascular mortality + myocardial infarction). The mean age was 63 ± 8 years; 69% were male. Diabetic end-organ damage was present in 87% of patients. Baseline SPECT was abnormal in 22% of patients. Median follow-up was 11.1 (8.8, 12.8) years. Abnormal SPECT was associated with higher all-cause mortality [hazard ratio (HR) 1.614, P = 0.029] and MACE (HR 2.024, P = 0.009). A normal SPECT was associated with a significantly better prognosis (all-cause mortality 1.9 vs. 3.1%/year, P = 0.016; MACE 1.2 vs. 2.3%/year, P = 0.010). In the small subgroup of patients with abnormal SPECT, the treatment strategy (revascularization vs. conservative) had no effect on event-free survival. Conclusion: A normal SPECT was associated with an excellent long-term prognosis in high-risk T2DM patients. Hence, SPECT could serve as a valuable tool for advanced risk stratification in this population.


  • Open Access

    Evaluation of three diagnostic algorithms to reduce normal scan rates, radiation exposure and costs in patients with suspected chronic coronary syndrome referred for 82Rb-Positron Emission Tomography (82Rb-PET)

    by Simon M Frey, Gabrielle Huré, Jan-Philipp Leibfarth, Kathrin Thommen, Melissa L Amrein, Ibrahim Schaefer, Klara Rumora, Igor G Schneider, Federico Caobelli, Damian Wild, et al.

    Background: The majority of functional ischemia tests in patients with suspected chronic coronary syndromes (CCS) yield normal results. Implementing gatekeepers for patient preselection, such as pretest probability (PTP) and/or coronary artery calcium score (CACS), could reduce the number of normal scan results, radiation exposure and costs. However, the efficacy and safety of these approaches remain unclear. Methods: Three diagnostic algorithms based on PTP, as summarised in the 2019 European Society of Cardiology (ESC) CCS guidelines, were retrospectively applied to 1792 patients with suspected CCS referred for 82Rb-Positron Emission Tomography (82Rb-PET): (1) defer testing if PTP ≤5%; (2) defer if PTP <15%; and (3) defer if PTP ≤5% or PTP 5–15% and CACS 0. The proportion of missed ischemia, number of scans and reduction of normal scan results, radiation exposure and costs were compared with the current gold standard (CACS+PET in every patient). Endpoints were defined as small ischemia (SDS ≥2) and relevant ischemia (≥10% of myocardium). Results: The mean age of the patients was 65±11 years, and 43% were female. PTP ≤5% and <15% were present in 7.5% and 41.0%, respectively. Algorithm 1 reduced scans, radiation and costs by 7.5% without significantly missing ischemia (sensitivity/negative predictive value (NPV) 98.6%/99.7%). Algorithm 2 showed the largest reduction (41.0%), but sensitivity was significantly reduced (80.2%). Algorithm 3 demonstrated optimal performance, reducing radiation by 17.0% and costs by 17.3% without significantly missing ischemia suggesting excellent safety (sensitivity/NPV 98.0%/99.5%). Conclusion: Using a diagnostic algorithm combining PTP and CACS (algorithm 3), the number of normal scan results, radiation exposure and costs could be significantly reduced without a significant increase in missed diagnoses suggesting similar outcome and excellent patients safety. Consequently, this approach could help to optimally allocate limited healthcare resources while maintaining patient’s safety.


  • Open Access

    Diagnostic utility of coronary artery calcium score percentiles and categories to exclude abnormal scans and relevant ischemia in rubidium positron emission tomography

    by Simon M. Frey, Gabrielle Huré, Jan-Philipp Leibfarth, Kathrin Thommen, Melissa Amrein, Klara Rumora, Ibrahim Schäfer, Federico Caobelli, Damian Wild, Philip Haaf, et al.

    Background: Despite clinical suspicion, most non-invasive ischemia tests for coronary artery disease (CAD) reveal unremarkable results. Patients with a coronary artery calcium score (CACS) of zero rarely have an abnormal positron emission tomography (PET) and could be deferred from further testing. However, most patients have some extent of coronary calcification.Objectives: CACS percentiles could be useful to exclude abnormal perfusion in patients with CACS >0, but data from patients with 82Rb PET are lacking. The aim of this study was to assess the diagnostic utility of CACS percentiles in comparison to zero calcium and absolute CACS classes.Methods: Consecutive patients with suspected CAD (n = 1,792) referred for 82Rb PET were included and analyzed for abnormal PET (SSS ≥4) and relevant ischemia (>10% myocardium). Test characteristics were calculated.Results: The mean age was 65 ± 11 years, 43% were female, and typical angina was reported in 21%. Abnormal PET/relevant ischemia (>10%) were observed in 19.8%/9.3%. Overall, the sensitivity/negative predictive value (NPV) of a 50 years, the 10%). They could be used to extend the scope of application of CACS 0 by 8%–10% to 32%–34% overall of patients who could be deferred from further testing.


  • Four-Dimensional Flow MRI in Adult Type Christmas Tree ALCAPA With High Cardiac Output

    by Philip Haaf, Daniel Tobler, Simon M. Frey, Stefan Gherca, Christian Gernhardt, Michael J. Zellweger, Jens Bremerich, Maurice Pradella


  • Open Access

    High-resolution free-breathing automated quantitative myocardial perfusion by cardiovascular magnetic resonance for the detection of functionally significant coronary artery disease

    by R Crawley, K P Kunze, X Milidonis, J Highton, S McElroy, S M Frey, D Hoefler, C Karamanli, N C K Wong, S J Backhaus, et al.

    Current assessment of myocardial ischaemia from stress perfusion cardiovascular magnetic resonance (SP-CMR) largely relies on visual interpretation. This study investigated the use of high-resolution free-breathing SP-CMR with automated quantitative mapping in the diagnosis of coronary artery disease (CAD). Diagnostic performance was evaluated against invasive coronary angiography (ICA) with fractional flow reserve (FFR) measurement. Seven hundred and three patients were recruited for SP-CMR using the research sequence at 3 Tesla. Of those receiving ICA within 6 months, 80 patients had either FFR measurement or identification of a chronic total occlusion (CTO) with inducible perfusion defects seen on SP-CMR. Myocardial blood flow (MBF) maps were automatically generated in-line on the scanner following image acquisition at hyperaemic stress and rest, allowing myocardial perfusion reserve (MPR) calculation. Seventy-five coronary vessels assessed by FFR and 28 vessels with CTO were evaluated at both segmental and coronary territory level. Coronary territory stress MBF and MPR were reduced in FFR-positive (≤0.80) regions [median stress MBF: 1.74 (0.90–2.17) mL/min/g; MPR: 1.67 (1.10–1.89)] compared with FFR-negative regions [stress MBF: 2.50 (2.15–2.95) mL/min/g; MPR 2.35 (2.06–2.54) P < 0.001 for both]. Stress MBF ≤ 1.94 mL/min/g and MPR ≤ 1.97 accurately detected FFR-positive CAD on a per-vessel basis (area under the curve: 0.85 and 0.96, respectively; P < 0.001 for both). A novel scanner-integrated high-resolution free-breathing SP-CMR sequence with automated in-line perfusion mapping is presented which accurately detects functionally significant CAD. High-resolution free-breathing stress perfusion cardiovascular magnetic resonance (SP-CMR) with in-line automated quantitative mapping is accurate in the diagnosis of functionally significant coronary artery disease. Diagnostic performance was compared with invasive fractional flow reserve (FFR) with myocardial blood flow (MBF) at hyperaemic stress and myocardial perfusion reserve (MPR) reduced in patients with inducible ischaemia. CTO, chronic total occlusion; AUC, area under the curve.


  • Open Access

    Artificial intelligence to improve ischemia prediction in Rubidium Positron Emission Tomography—a validation study

    by Simon M. Frey, Adam Bakula, Andrew Tsirkin, Vasily Vasilchenko, Peter Ruff, Caroline Oehri, Melissa Fee Amrein, Gabrielle Huré, Klara Rumora, Ibrahim Schäfer, et al.

    Background: Patients are referred to functional coronary artery disease (CAD) testing based on their pre-test probability (PTP) to search for myocardial ischemia. The recommended prediction tools incorporate three variables (symptoms, age, sex) and are easy to use, but have a limited diagnostic accuracy. Hence, a substantial proportion of non-invasive functional tests reveal no myocardial ischemia, leading to unnecessary radiation exposure and costs. Therefore, preselection of patients before ischemia testing needs to be improved using a more predictive and personalised approach. Aims: Using multiple variables (symptoms, vitals, ECG, biomarkers), artificial intelligence–based tools can provide a detailed and individualised profile of each patient. This could improve PTP assessment and provide a more personalised diagnostic approach in the framework of predictive, preventive and personalised medicine (PPPM). Methods: Consecutive patients (n = 2417) referred for Rubidium-82 positron emission tomography were evaluated. PTP was calculated using the ESC 2013/2019 and ACC 2012/2021 guidelines, and a memetic pattern–based algorithm (MPA) was applied incorporating symptoms, vitals, ECG and biomarkers. Five PTP categories from very low to very high PTP were defined (i.e., < 5%, 5–15%, 15–50%, 50–85%, > 85%). Ischemia was defined as summed difference score (SDS) ≥ 2. Results: Ischemia was present in 37.1%. The MPA model was most accurate to predict ischemia (AUC: 0.758, p < 0.001 compared to ESC 2013, 0.661; ESC 2019, 0.673; ACC 2012, 0.585; ACC 2021, 0.667). Using the < 5% threshold, the MPA’s sensitivity and negative predictive value to rule out ischemia were 99.1% and 96.4%, respectively. The model allocated patients more evenly across PTP categories, reduced the proportion of patients in the intermediate (15–85%) range by 29% (ACC 2012)–51% (ESC 2019), and was the only tool to correctly predict ischemia prevalence in the very low PTP category. Conclusion: The MPA model enhanced ischemia testing according to the PPPM framework: The MPA model improved individual prediction of ischemia significantly and could safely exclude ischemia based on readily available variables without advanced testing (“predictive”). It reduced the proportion of patients in the intermediate PTP range. Therefore, it could be used as a gatekeeper to prevent patients from further unnecessary downstream testing, radiation exposure and costs (“preventive”). Consequently, the MPA model could transform ischemia testing towards a more personalised diagnostic algorithm (“personalised”).